| Mr Christopher J Orton, RN | |
|
3200 N Silver St, Silver City, NM 88061-7283 | |
| (575) 956-2132 | |
| Not Available |
| Full Name | Mr Christopher J Orton |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse - School |
| Location | 3200 N Silver St, Silver City, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144004524 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WS0200X | Registered Nurse - School | RN80024 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Christopher J Orton, RN 14 Cherry St, Arenas Valley, NM 88022-9749 Ph: (575) 574-7390 | Mr Christopher J Orton, RN 3200 N Silver St, Silver City, NM 88061-7283 Ph: (575) 956-2132 |
News Archive
Northwestern Memorial Hospital's emergency department treats approximately 1,000 traumas annually, one third of which are related to shooting or stabbing incidents. In response, Northwestern Memorial has become a CeaseFire site and has staffed its emergency department with violence interrupters who are specially trained to intervene and minimize the risk of retaliation or repeat injury following a violent incident.
Pharmalink AB, a specialty pharma company focused on orphan and niche products, today announces its product Busulipo, a best-in-class conditioning agent for use in cancer patients prior to hematopoietic stem cell transplantation (HSCT; also known as bone marrow transplantation), has received orphan drug designation from the US Food and Drug Administration.
A new study appearing in the September issue of the Journal of Clinical Investigation indicates that caution might be needed if a new group of drugs known as estrens are to be developed for the treatment of osteoporosis.
Antigenics Inc. reported today its results for the quarter and year ended December 31, 2009. The company reported net income attributable to common stockholders of $1.7 million, or $0.02 per share, basic and diluted, for the fourth quarter of 2009, compared with net income attributable to common stockholders in the fourth quarter of 2008 of $3.9 million, or $0.06 per share, basic and diluted.
If narrowed or blocked coronary vessels have to be widened or opened, a vascular support (stent) is usually inserted. Drug-coated stents are preferred for patients at high risk of renewed narrowing of vessels (restenosis). However, the use of antibody-coated stents has been increasing in recent years. Current studies provide indications that these new antibody-coated stents more frequently lead to myocardial infarction and make re-operation necessary.
› Verified 5 days ago
Mrs. Brandi Dawn De La Torre, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 315 S Hudson St, Silver City, NM 88061 Phone: 575-388-4497 Fax: 575-534-1150 | |
Jill Colleen Eastep, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2810 N Swan St, Silver City, NM 88061 Phone: 575-956-2172 Fax: 575-956-2182 | |
Sherri Richey, MSN-RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3500 N Silver St, Silver City, NM 88061 Phone: 575-956-2060 Fax: 575-956-2098 | |
Brenda Ann Woods, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2810 N Swan St, Silver City, NM 88061 Phone: 575-956-2000 | |
Angela Dawn Cox, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 720 E Apache St, Silver City, NM 88061 Phone: 806-627-7067 | |
Amy Souders Potts, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 600 E 32nd St, Silver City, NM 88061 Phone: 575-956-2140 |